Last updated: April 10, 2025
Sponsor: Temple University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chronic Obstructive Pulmonary Disease (Copd)
Emphysema
Bronchiectasis
Treatment
Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio
Clinical Study ID
NCT06933758
THCI 2.0 RESEARCH PLAN
Ages 50-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
50 to 80 years old
Screened for early lung cancer using low dose CT imaging
Exclusion
Exclusion Criteria:
Under 50; over 80 years old
No lung cancer screening
Study Design
Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio
Phase:
Study Start date:
February 28, 2025
Estimated Completion Date:
June 30, 2026
Study Description
Connect with a study center
Temple University Of the Commonwealth System of Higher Education
Philadelphia, Pennsylvania 19140
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.